Global Equine Healthcare

Equine Healthcare Comprehensive Study by Type (Supplement Product, Therapeutic Product, Diagnostic Product), Application (Race Equine, Sport Equine), Therapeutic (Equine Therapeutics Market, Equine Vaccines Market), Distribution Channel (Veterinary Hospitals and Clinics, Retail Pharmacies and Drug Stores, Others), Supplement (Equine Performance Supplements, Equine Protection Supplements), Diagnostic (Equine Pregnancy, Gestation Diagnostic Products, Equine Genotyping Analysis Products) Players and Region - Global Market Outlook to 2030

Equine Healthcare Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Equine Healthcare
Horses are considered sports animals, companion animals, and working animals and provide employment and financial gain in several developed and developing countries. World equestrian market consists of horse racing and betting, competitive riding and leisure. It supports varied secondary markets of that equine healthcare is major. This market includes equine diagnostic merchandise, supplement merchandise and therapeutic merchandise. The participants attracted by high come on investment (ROI) are resulting in market growth. Also, investment by varied alternative nations in racing is driving the expansion of this market. However, handiness of alternatives to gambling like online betting and therefore the declining population of equine is limiting the expansion of this market.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


The players are highly fragmented in the market. The growing focus of animal care in the region, rising affordability and awareness of equine healthcare products in countries. Moreover, growing demand for equine insurance in the developed countries will further drive the market. However, legislation on horse racing will hinder the market. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Equine Healthcare market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Merck Animal Health (United States), Boehringer Ingelheim Vetmedica (Germany), Affymetrix (United States), Elanco Animal Heath (United States), Zoetis (Pfizer Animal Health) (United States), Equine Health U.K. (United Kingdom), Nutreco N.V. (Netherlands), Phirbo Animal Health (United States), Bayer (Germany), Cargill (United States), Dechra Pharmaceuticals (United Kingdom), Ceva Sante Animale (France), Evonik Industries (Germany) and Eli Lilly and Company (United States) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global Equine Healthcare market by Type (Supplement Product, Therapeutic Product and Diagnostic Product), Application (Race Equine and Sport Equine) and Region.



On the basis of geography, the market of Equine Healthcare has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Therapeutic , the sub-segment i.e. Equine Therapeutics Market will boost the Equine Healthcare market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Distribution Channel, the sub-segment i.e. Veterinary Hospitals and Clinics will boost the Equine Healthcare market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Supplement, the sub-segment i.e. Equine Performance Supplements will boost the Equine Healthcare market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Diagnostic, the sub-segment i.e. Equine Pregnancy will boost the Equine Healthcare market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Growing Demand for Equine Insurance in The Developed Countries

Market Growth Drivers:
The Growing Popularity of Horse Racing in Developed and Developing Regions, Growing Awareness and Affordability of Equine Healthcare Products and High Equine Adoption Rate in The Household

Challenges:
Lack Of Awareness About the Various Products in The Under-Developed Regions and Increasing Trend of The Indoor Games Like Gambling Have Affected the Sale

Restraints:
Strict Regulations Associated with Horse Racing and Horse Breeding Activities

Opportunities:
Increase In Research and Development Activities and Increased Sale of Products

Market Leaders and their expansionary development strategies
In January 2024, Altano Group announces the acquisition of McKee Pownall Equine Services, an equine veterinary medicine in the greater Toronto, Ontario, area. The pair view the strategic partnership as a significant step in Altano’s commitment to shaping the future of global equine healthcare.
in June 2021, Epona Biotec, a veterinary startup dedicated to advancing equine health care, launched the VetTrue System, a remote temperature-monitoring system for horses. A team of veterinary, equestrian, and technology professionals developed the VetTrue System to provide a more accurate, less invasive health-monitoring solution for veterinarians, horse owners, and professionals in the equestrian industry. The VetTrue System makes use of a single-use TailTab temperature sensor that is securely attached beneath the tail. Once implanted, the horse's temperature is continuously monitored and transferred to the VetTrue App through Bluetooth.


Key Target Audience
Manufacturers of Equine Healthcare, Suppliers and distributors of Equine Healthcare, Governmental and Regulatory bodies and End-Users

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Supplement Product
  • Therapeutic Product
  • Diagnostic Product
By Application
  • Race Equine
  • Sport Equine
By Therapeutic
  • Equine Therapeutics Market
  • Equine Vaccines Market

By Distribution Channel
  • Veterinary Hospitals and Clinics
  • Retail Pharmacies and Drug Stores
  • Others

By Supplement
  • Equine Performance Supplements
  • Equine Protection Supplements

By Diagnostic
  • Equine Pregnancy
  • Gestation Diagnostic Products
  • Equine Genotyping Analysis Products

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The Growing Popularity of Horse Racing in Developed and Developing Regions
      • 3.2.2. Growing Awareness and Affordability of Equine Healthcare Products
      • 3.2.3. High Equine Adoption Rate in The Household
    • 3.3. Market Challenges
      • 3.3.1. Lack Of Awareness About the Various Products in The Under-Developed Regions
      • 3.3.2. Increasing Trend of The Indoor Games Like Gambling Have Affected the Sale
    • 3.4. Market Trends
      • 3.4.1. Growing Demand for Equine Insurance in The Developed Countries
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Equine Healthcare, by Type, Application, Therapeutic , Distribution Channel, Supplement, Diagnostic and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Equine Healthcare (Value)
      • 5.2.1. Global Equine Healthcare by: Type (Value)
        • 5.2.1.1. Supplement Product
        • 5.2.1.2. Therapeutic Product
        • 5.2.1.3. Diagnostic Product
      • 5.2.2. Global Equine Healthcare by: Application (Value)
        • 5.2.2.1. Race Equine
        • 5.2.2.2. Sport Equine
      • 5.2.3. Global Equine Healthcare by: Distribution Channel (Value)
        • 5.2.3.1. Veterinary Hospitals and Clinics
        • 5.2.3.2. Retail Pharmacies and Drug Stores
        • 5.2.3.3. Others
      • 5.2.4. Global Equine Healthcare by: Supplement (Value)
        • 5.2.4.1. Equine Performance Supplements
        • 5.2.4.2. Equine Protection Supplements
      • 5.2.5. Global Equine Healthcare by: Diagnostic (Value)
        • 5.2.5.1. Equine Pregnancy
        • 5.2.5.2. Gestation Diagnostic Products
        • 5.2.5.3. Equine Genotyping Analysis Products
      • 5.2.6. Global Equine Healthcare Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
    • 5.3. Global Equine Healthcare (Price)
      • 5.3.1. Global Equine Healthcare by: Type (Price)
  • 6. Equine Healthcare: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Merck Animal Health (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Boehringer Ingelheim Vetmedica (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Affymetrix (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Elanco Animal Heath (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Zoetis (Pfizer Animal Health) (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Equine Health U.K. (United Kingdom)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Nutreco N.V. (Netherlands)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Phirbo Animal Health (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Bayer (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Cargill (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Dechra Pharmaceuticals (United Kingdom)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Ceva Sante Animale (France)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Evonik Industries (Germany)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. Eli Lilly and Company (United States)
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
  • 7. Global Equine Healthcare Sale, by Type, Application, Therapeutic , Distribution Channel, Supplement, Diagnostic and Region (value and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Equine Healthcare (Value)
      • 7.2.1. Global Equine Healthcare by: Type (Value)
        • 7.2.1.1. Supplement Product
        • 7.2.1.2. Therapeutic Product
        • 7.2.1.3. Diagnostic Product
      • 7.2.2. Global Equine Healthcare by: Application (Value)
        • 7.2.2.1. Race Equine
        • 7.2.2.2. Sport Equine
      • 7.2.3. Global Equine Healthcare by: Distribution Channel (Value)
        • 7.2.3.1. Veterinary Hospitals and Clinics
        • 7.2.3.2. Retail Pharmacies and Drug Stores
        • 7.2.3.3. Others
      • 7.2.4. Global Equine Healthcare by: Supplement (Value)
        • 7.2.4.1. Equine Performance Supplements
        • 7.2.4.2. Equine Protection Supplements
      • 7.2.5. Global Equine Healthcare by: Diagnostic (Value)
        • 7.2.5.1. Equine Pregnancy
        • 7.2.5.2. Gestation Diagnostic Products
        • 7.2.5.3. Equine Genotyping Analysis Products
      • 7.2.6. Global Equine Healthcare Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
    • 7.3. Global Equine Healthcare (Price)
      • 7.3.1. Global Equine Healthcare by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Equine Healthcare: by Type(USD Million)
  • Table 2. Equine Healthcare Supplement Product , by Region USD Million (2018-2023)
  • Table 3. Equine Healthcare Therapeutic Product , by Region USD Million (2018-2023)
  • Table 4. Equine Healthcare Diagnostic Product , by Region USD Million (2018-2023)
  • Table 5. Equine Healthcare: by Application(USD Million)
  • Table 6. Equine Healthcare Race Equine , by Region USD Million (2018-2023)
  • Table 7. Equine Healthcare Sport Equine , by Region USD Million (2018-2023)
  • Table 8. Equine Healthcare: by Distribution Channel(USD Million)
  • Table 9. Equine Healthcare Veterinary Hospitals and Clinics , by Region USD Million (2018-2023)
  • Table 10. Equine Healthcare Retail Pharmacies and Drug Stores , by Region USD Million (2018-2023)
  • Table 11. Equine Healthcare Others , by Region USD Million (2018-2023)
  • Table 12. Equine Healthcare: by Supplement(USD Million)
  • Table 13. Equine Healthcare Equine Performance Supplements , by Region USD Million (2018-2023)
  • Table 14. Equine Healthcare Equine Protection Supplements , by Region USD Million (2018-2023)
  • Table 15. Equine Healthcare: by Diagnostic(USD Million)
  • Table 16. Equine Healthcare Equine Pregnancy , by Region USD Million (2018-2023)
  • Table 17. Equine Healthcare Gestation Diagnostic Products , by Region USD Million (2018-2023)
  • Table 18. Equine Healthcare Equine Genotyping Analysis Products , by Region USD Million (2018-2023)
  • Table 19. South America Equine Healthcare, by Country USD Million (2018-2023)
  • Table 20. South America Equine Healthcare, by Type USD Million (2018-2023)
  • Table 21. South America Equine Healthcare, by Application USD Million (2018-2023)
  • Table 22. South America Equine Healthcare, by Therapeutic USD Million (2018-2023)
  • Table 23. South America Equine Healthcare, by Distribution Channel USD Million (2018-2023)
  • Table 24. South America Equine Healthcare, by Supplement USD Million (2018-2023)
  • Table 25. South America Equine Healthcare, by Diagnostic USD Million (2018-2023)
  • Table 26. Brazil Equine Healthcare, by Type USD Million (2018-2023)
  • Table 27. Brazil Equine Healthcare, by Application USD Million (2018-2023)
  • Table 28. Brazil Equine Healthcare, by Therapeutic USD Million (2018-2023)
  • Table 29. Brazil Equine Healthcare, by Distribution Channel USD Million (2018-2023)
  • Table 30. Brazil Equine Healthcare, by Supplement USD Million (2018-2023)
  • Table 31. Brazil Equine Healthcare, by Diagnostic USD Million (2018-2023)
  • Table 32. Argentina Equine Healthcare, by Type USD Million (2018-2023)
  • Table 33. Argentina Equine Healthcare, by Application USD Million (2018-2023)
  • Table 34. Argentina Equine Healthcare, by Therapeutic USD Million (2018-2023)
  • Table 35. Argentina Equine Healthcare, by Distribution Channel USD Million (2018-2023)
  • Table 36. Argentina Equine Healthcare, by Supplement USD Million (2018-2023)
  • Table 37. Argentina Equine Healthcare, by Diagnostic USD Million (2018-2023)
  • Table 38. Rest of South America Equine Healthcare, by Type USD Million (2018-2023)
  • Table 39. Rest of South America Equine Healthcare, by Application USD Million (2018-2023)
  • Table 40. Rest of South America Equine Healthcare, by Therapeutic USD Million (2018-2023)
  • Table 41. Rest of South America Equine Healthcare, by Distribution Channel USD Million (2018-2023)
  • Table 42. Rest of South America Equine Healthcare, by Supplement USD Million (2018-2023)
  • Table 43. Rest of South America Equine Healthcare, by Diagnostic USD Million (2018-2023)
  • Table 44. Asia Pacific Equine Healthcare, by Country USD Million (2018-2023)
  • Table 45. Asia Pacific Equine Healthcare, by Type USD Million (2018-2023)
  • Table 46. Asia Pacific Equine Healthcare, by Application USD Million (2018-2023)
  • Table 47. Asia Pacific Equine Healthcare, by Therapeutic USD Million (2018-2023)
  • Table 48. Asia Pacific Equine Healthcare, by Distribution Channel USD Million (2018-2023)
  • Table 49. Asia Pacific Equine Healthcare, by Supplement USD Million (2018-2023)
  • Table 50. Asia Pacific Equine Healthcare, by Diagnostic USD Million (2018-2023)
  • Table 51. China Equine Healthcare, by Type USD Million (2018-2023)
  • Table 52. China Equine Healthcare, by Application USD Million (2018-2023)
  • Table 53. China Equine Healthcare, by Therapeutic USD Million (2018-2023)
  • Table 54. China Equine Healthcare, by Distribution Channel USD Million (2018-2023)
  • Table 55. China Equine Healthcare, by Supplement USD Million (2018-2023)
  • Table 56. China Equine Healthcare, by Diagnostic USD Million (2018-2023)
  • Table 57. Japan Equine Healthcare, by Type USD Million (2018-2023)
  • Table 58. Japan Equine Healthcare, by Application USD Million (2018-2023)
  • Table 59. Japan Equine Healthcare, by Therapeutic USD Million (2018-2023)
  • Table 60. Japan Equine Healthcare, by Distribution Channel USD Million (2018-2023)
  • Table 61. Japan Equine Healthcare, by Supplement USD Million (2018-2023)
  • Table 62. Japan Equine Healthcare, by Diagnostic USD Million (2018-2023)
  • Table 63. India Equine Healthcare, by Type USD Million (2018-2023)
  • Table 64. India Equine Healthcare, by Application USD Million (2018-2023)
  • Table 65. India Equine Healthcare, by Therapeutic USD Million (2018-2023)
  • Table 66. India Equine Healthcare, by Distribution Channel USD Million (2018-2023)
  • Table 67. India Equine Healthcare, by Supplement USD Million (2018-2023)
  • Table 68. India Equine Healthcare, by Diagnostic USD Million (2018-2023)
  • Table 69. South Korea Equine Healthcare, by Type USD Million (2018-2023)
  • Table 70. South Korea Equine Healthcare, by Application USD Million (2018-2023)
  • Table 71. South Korea Equine Healthcare, by Therapeutic USD Million (2018-2023)
  • Table 72. South Korea Equine Healthcare, by Distribution Channel USD Million (2018-2023)
  • Table 73. South Korea Equine Healthcare, by Supplement USD Million (2018-2023)
  • Table 74. South Korea Equine Healthcare, by Diagnostic USD Million (2018-2023)
  • Table 75. Taiwan Equine Healthcare, by Type USD Million (2018-2023)
  • Table 76. Taiwan Equine Healthcare, by Application USD Million (2018-2023)
  • Table 77. Taiwan Equine Healthcare, by Therapeutic USD Million (2018-2023)
  • Table 78. Taiwan Equine Healthcare, by Distribution Channel USD Million (2018-2023)
  • Table 79. Taiwan Equine Healthcare, by Supplement USD Million (2018-2023)
  • Table 80. Taiwan Equine Healthcare, by Diagnostic USD Million (2018-2023)
  • Table 81. Australia Equine Healthcare, by Type USD Million (2018-2023)
  • Table 82. Australia Equine Healthcare, by Application USD Million (2018-2023)
  • Table 83. Australia Equine Healthcare, by Therapeutic USD Million (2018-2023)
  • Table 84. Australia Equine Healthcare, by Distribution Channel USD Million (2018-2023)
  • Table 85. Australia Equine Healthcare, by Supplement USD Million (2018-2023)
  • Table 86. Australia Equine Healthcare, by Diagnostic USD Million (2018-2023)
  • Table 87. Rest of Asia-Pacific Equine Healthcare, by Type USD Million (2018-2023)
  • Table 88. Rest of Asia-Pacific Equine Healthcare, by Application USD Million (2018-2023)
  • Table 89. Rest of Asia-Pacific Equine Healthcare, by Therapeutic USD Million (2018-2023)
  • Table 90. Rest of Asia-Pacific Equine Healthcare, by Distribution Channel USD Million (2018-2023)
  • Table 91. Rest of Asia-Pacific Equine Healthcare, by Supplement USD Million (2018-2023)
  • Table 92. Rest of Asia-Pacific Equine Healthcare, by Diagnostic USD Million (2018-2023)
  • Table 93. Europe Equine Healthcare, by Country USD Million (2018-2023)
  • Table 94. Europe Equine Healthcare, by Type USD Million (2018-2023)
  • Table 95. Europe Equine Healthcare, by Application USD Million (2018-2023)
  • Table 96. Europe Equine Healthcare, by Therapeutic USD Million (2018-2023)
  • Table 97. Europe Equine Healthcare, by Distribution Channel USD Million (2018-2023)
  • Table 98. Europe Equine Healthcare, by Supplement USD Million (2018-2023)
  • Table 99. Europe Equine Healthcare, by Diagnostic USD Million (2018-2023)
  • Table 100. Germany Equine Healthcare, by Type USD Million (2018-2023)
  • Table 101. Germany Equine Healthcare, by Application USD Million (2018-2023)
  • Table 102. Germany Equine Healthcare, by Therapeutic USD Million (2018-2023)
  • Table 103. Germany Equine Healthcare, by Distribution Channel USD Million (2018-2023)
  • Table 104. Germany Equine Healthcare, by Supplement USD Million (2018-2023)
  • Table 105. Germany Equine Healthcare, by Diagnostic USD Million (2018-2023)
  • Table 106. France Equine Healthcare, by Type USD Million (2018-2023)
  • Table 107. France Equine Healthcare, by Application USD Million (2018-2023)
  • Table 108. France Equine Healthcare, by Therapeutic USD Million (2018-2023)
  • Table 109. France Equine Healthcare, by Distribution Channel USD Million (2018-2023)
  • Table 110. France Equine Healthcare, by Supplement USD Million (2018-2023)
  • Table 111. France Equine Healthcare, by Diagnostic USD Million (2018-2023)
  • Table 112. Italy Equine Healthcare, by Type USD Million (2018-2023)
  • Table 113. Italy Equine Healthcare, by Application USD Million (2018-2023)
  • Table 114. Italy Equine Healthcare, by Therapeutic USD Million (2018-2023)
  • Table 115. Italy Equine Healthcare, by Distribution Channel USD Million (2018-2023)
  • Table 116. Italy Equine Healthcare, by Supplement USD Million (2018-2023)
  • Table 117. Italy Equine Healthcare, by Diagnostic USD Million (2018-2023)
  • Table 118. United Kingdom Equine Healthcare, by Type USD Million (2018-2023)
  • Table 119. United Kingdom Equine Healthcare, by Application USD Million (2018-2023)
  • Table 120. United Kingdom Equine Healthcare, by Therapeutic USD Million (2018-2023)
  • Table 121. United Kingdom Equine Healthcare, by Distribution Channel USD Million (2018-2023)
  • Table 122. United Kingdom Equine Healthcare, by Supplement USD Million (2018-2023)
  • Table 123. United Kingdom Equine Healthcare, by Diagnostic USD Million (2018-2023)
  • Table 124. Netherlands Equine Healthcare, by Type USD Million (2018-2023)
  • Table 125. Netherlands Equine Healthcare, by Application USD Million (2018-2023)
  • Table 126. Netherlands Equine Healthcare, by Therapeutic USD Million (2018-2023)
  • Table 127. Netherlands Equine Healthcare, by Distribution Channel USD Million (2018-2023)
  • Table 128. Netherlands Equine Healthcare, by Supplement USD Million (2018-2023)
  • Table 129. Netherlands Equine Healthcare, by Diagnostic USD Million (2018-2023)
  • Table 130. Rest of Europe Equine Healthcare, by Type USD Million (2018-2023)
  • Table 131. Rest of Europe Equine Healthcare, by Application USD Million (2018-2023)
  • Table 132. Rest of Europe Equine Healthcare, by Therapeutic USD Million (2018-2023)
  • Table 133. Rest of Europe Equine Healthcare, by Distribution Channel USD Million (2018-2023)
  • Table 134. Rest of Europe Equine Healthcare, by Supplement USD Million (2018-2023)
  • Table 135. Rest of Europe Equine Healthcare, by Diagnostic USD Million (2018-2023)
  • Table 136. MEA Equine Healthcare, by Country USD Million (2018-2023)
  • Table 137. MEA Equine Healthcare, by Type USD Million (2018-2023)
  • Table 138. MEA Equine Healthcare, by Application USD Million (2018-2023)
  • Table 139. MEA Equine Healthcare, by Therapeutic USD Million (2018-2023)
  • Table 140. MEA Equine Healthcare, by Distribution Channel USD Million (2018-2023)
  • Table 141. MEA Equine Healthcare, by Supplement USD Million (2018-2023)
  • Table 142. MEA Equine Healthcare, by Diagnostic USD Million (2018-2023)
  • Table 143. Middle East Equine Healthcare, by Type USD Million (2018-2023)
  • Table 144. Middle East Equine Healthcare, by Application USD Million (2018-2023)
  • Table 145. Middle East Equine Healthcare, by Therapeutic USD Million (2018-2023)
  • Table 146. Middle East Equine Healthcare, by Distribution Channel USD Million (2018-2023)
  • Table 147. Middle East Equine Healthcare, by Supplement USD Million (2018-2023)
  • Table 148. Middle East Equine Healthcare, by Diagnostic USD Million (2018-2023)
  • Table 149. Africa Equine Healthcare, by Type USD Million (2018-2023)
  • Table 150. Africa Equine Healthcare, by Application USD Million (2018-2023)
  • Table 151. Africa Equine Healthcare, by Therapeutic USD Million (2018-2023)
  • Table 152. Africa Equine Healthcare, by Distribution Channel USD Million (2018-2023)
  • Table 153. Africa Equine Healthcare, by Supplement USD Million (2018-2023)
  • Table 154. Africa Equine Healthcare, by Diagnostic USD Million (2018-2023)
  • Table 155. North America Equine Healthcare, by Country USD Million (2018-2023)
  • Table 156. North America Equine Healthcare, by Type USD Million (2018-2023)
  • Table 157. North America Equine Healthcare, by Application USD Million (2018-2023)
  • Table 158. North America Equine Healthcare, by Therapeutic USD Million (2018-2023)
  • Table 159. North America Equine Healthcare, by Distribution Channel USD Million (2018-2023)
  • Table 160. North America Equine Healthcare, by Supplement USD Million (2018-2023)
  • Table 161. North America Equine Healthcare, by Diagnostic USD Million (2018-2023)
  • Table 162. United States Equine Healthcare, by Type USD Million (2018-2023)
  • Table 163. United States Equine Healthcare, by Application USD Million (2018-2023)
  • Table 164. United States Equine Healthcare, by Therapeutic USD Million (2018-2023)
  • Table 165. United States Equine Healthcare, by Distribution Channel USD Million (2018-2023)
  • Table 166. United States Equine Healthcare, by Supplement USD Million (2018-2023)
  • Table 167. United States Equine Healthcare, by Diagnostic USD Million (2018-2023)
  • Table 168. Canada Equine Healthcare, by Type USD Million (2018-2023)
  • Table 169. Canada Equine Healthcare, by Application USD Million (2018-2023)
  • Table 170. Canada Equine Healthcare, by Therapeutic USD Million (2018-2023)
  • Table 171. Canada Equine Healthcare, by Distribution Channel USD Million (2018-2023)
  • Table 172. Canada Equine Healthcare, by Supplement USD Million (2018-2023)
  • Table 173. Canada Equine Healthcare, by Diagnostic USD Million (2018-2023)
  • Table 174. Mexico Equine Healthcare, by Type USD Million (2018-2023)
  • Table 175. Mexico Equine Healthcare, by Application USD Million (2018-2023)
  • Table 176. Mexico Equine Healthcare, by Therapeutic USD Million (2018-2023)
  • Table 177. Mexico Equine Healthcare, by Distribution Channel USD Million (2018-2023)
  • Table 178. Mexico Equine Healthcare, by Supplement USD Million (2018-2023)
  • Table 179. Mexico Equine Healthcare, by Diagnostic USD Million (2018-2023)
  • Table 180. Equine Healthcare: by Type(USD/Units)
  • Table 181. Company Basic Information, Sales Area and Its Competitors
  • Table 182. Company Basic Information, Sales Area and Its Competitors
  • Table 183. Company Basic Information, Sales Area and Its Competitors
  • Table 184. Company Basic Information, Sales Area and Its Competitors
  • Table 185. Company Basic Information, Sales Area and Its Competitors
  • Table 186. Company Basic Information, Sales Area and Its Competitors
  • Table 187. Company Basic Information, Sales Area and Its Competitors
  • Table 188. Company Basic Information, Sales Area and Its Competitors
  • Table 189. Company Basic Information, Sales Area and Its Competitors
  • Table 190. Company Basic Information, Sales Area and Its Competitors
  • Table 191. Company Basic Information, Sales Area and Its Competitors
  • Table 192. Company Basic Information, Sales Area and Its Competitors
  • Table 193. Company Basic Information, Sales Area and Its Competitors
  • Table 194. Company Basic Information, Sales Area and Its Competitors
  • Table 195. Equine Healthcare: by Type(USD Million)
  • Table 196. Equine Healthcare Supplement Product , by Region USD Million (2025-2030)
  • Table 197. Equine Healthcare Therapeutic Product , by Region USD Million (2025-2030)
  • Table 198. Equine Healthcare Diagnostic Product , by Region USD Million (2025-2030)
  • Table 199. Equine Healthcare: by Application(USD Million)
  • Table 200. Equine Healthcare Race Equine , by Region USD Million (2025-2030)
  • Table 201. Equine Healthcare Sport Equine , by Region USD Million (2025-2030)
  • Table 202. Equine Healthcare: by Distribution Channel(USD Million)
  • Table 203. Equine Healthcare Veterinary Hospitals and Clinics , by Region USD Million (2025-2030)
  • Table 204. Equine Healthcare Retail Pharmacies and Drug Stores , by Region USD Million (2025-2030)
  • Table 205. Equine Healthcare Others , by Region USD Million (2025-2030)
  • Table 206. Equine Healthcare: by Supplement(USD Million)
  • Table 207. Equine Healthcare Equine Performance Supplements , by Region USD Million (2025-2030)
  • Table 208. Equine Healthcare Equine Protection Supplements , by Region USD Million (2025-2030)
  • Table 209. Equine Healthcare: by Diagnostic(USD Million)
  • Table 210. Equine Healthcare Equine Pregnancy , by Region USD Million (2025-2030)
  • Table 211. Equine Healthcare Gestation Diagnostic Products , by Region USD Million (2025-2030)
  • Table 212. Equine Healthcare Equine Genotyping Analysis Products , by Region USD Million (2025-2030)
  • Table 213. South America Equine Healthcare, by Country USD Million (2025-2030)
  • Table 214. South America Equine Healthcare, by Type USD Million (2025-2030)
  • Table 215. South America Equine Healthcare, by Application USD Million (2025-2030)
  • Table 216. South America Equine Healthcare, by Therapeutic USD Million (2025-2030)
  • Table 217. South America Equine Healthcare, by Distribution Channel USD Million (2025-2030)
  • Table 218. South America Equine Healthcare, by Supplement USD Million (2025-2030)
  • Table 219. South America Equine Healthcare, by Diagnostic USD Million (2025-2030)
  • Table 220. Brazil Equine Healthcare, by Type USD Million (2025-2030)
  • Table 221. Brazil Equine Healthcare, by Application USD Million (2025-2030)
  • Table 222. Brazil Equine Healthcare, by Therapeutic USD Million (2025-2030)
  • Table 223. Brazil Equine Healthcare, by Distribution Channel USD Million (2025-2030)
  • Table 224. Brazil Equine Healthcare, by Supplement USD Million (2025-2030)
  • Table 225. Brazil Equine Healthcare, by Diagnostic USD Million (2025-2030)
  • Table 226. Argentina Equine Healthcare, by Type USD Million (2025-2030)
  • Table 227. Argentina Equine Healthcare, by Application USD Million (2025-2030)
  • Table 228. Argentina Equine Healthcare, by Therapeutic USD Million (2025-2030)
  • Table 229. Argentina Equine Healthcare, by Distribution Channel USD Million (2025-2030)
  • Table 230. Argentina Equine Healthcare, by Supplement USD Million (2025-2030)
  • Table 231. Argentina Equine Healthcare, by Diagnostic USD Million (2025-2030)
  • Table 232. Rest of South America Equine Healthcare, by Type USD Million (2025-2030)
  • Table 233. Rest of South America Equine Healthcare, by Application USD Million (2025-2030)
  • Table 234. Rest of South America Equine Healthcare, by Therapeutic USD Million (2025-2030)
  • Table 235. Rest of South America Equine Healthcare, by Distribution Channel USD Million (2025-2030)
  • Table 236. Rest of South America Equine Healthcare, by Supplement USD Million (2025-2030)
  • Table 237. Rest of South America Equine Healthcare, by Diagnostic USD Million (2025-2030)
  • Table 238. Asia Pacific Equine Healthcare, by Country USD Million (2025-2030)
  • Table 239. Asia Pacific Equine Healthcare, by Type USD Million (2025-2030)
  • Table 240. Asia Pacific Equine Healthcare, by Application USD Million (2025-2030)
  • Table 241. Asia Pacific Equine Healthcare, by Therapeutic USD Million (2025-2030)
  • Table 242. Asia Pacific Equine Healthcare, by Distribution Channel USD Million (2025-2030)
  • Table 243. Asia Pacific Equine Healthcare, by Supplement USD Million (2025-2030)
  • Table 244. Asia Pacific Equine Healthcare, by Diagnostic USD Million (2025-2030)
  • Table 245. China Equine Healthcare, by Type USD Million (2025-2030)
  • Table 246. China Equine Healthcare, by Application USD Million (2025-2030)
  • Table 247. China Equine Healthcare, by Therapeutic USD Million (2025-2030)
  • Table 248. China Equine Healthcare, by Distribution Channel USD Million (2025-2030)
  • Table 249. China Equine Healthcare, by Supplement USD Million (2025-2030)
  • Table 250. China Equine Healthcare, by Diagnostic USD Million (2025-2030)
  • Table 251. Japan Equine Healthcare, by Type USD Million (2025-2030)
  • Table 252. Japan Equine Healthcare, by Application USD Million (2025-2030)
  • Table 253. Japan Equine Healthcare, by Therapeutic USD Million (2025-2030)
  • Table 254. Japan Equine Healthcare, by Distribution Channel USD Million (2025-2030)
  • Table 255. Japan Equine Healthcare, by Supplement USD Million (2025-2030)
  • Table 256. Japan Equine Healthcare, by Diagnostic USD Million (2025-2030)
  • Table 257. India Equine Healthcare, by Type USD Million (2025-2030)
  • Table 258. India Equine Healthcare, by Application USD Million (2025-2030)
  • Table 259. India Equine Healthcare, by Therapeutic USD Million (2025-2030)
  • Table 260. India Equine Healthcare, by Distribution Channel USD Million (2025-2030)
  • Table 261. India Equine Healthcare, by Supplement USD Million (2025-2030)
  • Table 262. India Equine Healthcare, by Diagnostic USD Million (2025-2030)
  • Table 263. South Korea Equine Healthcare, by Type USD Million (2025-2030)
  • Table 264. South Korea Equine Healthcare, by Application USD Million (2025-2030)
  • Table 265. South Korea Equine Healthcare, by Therapeutic USD Million (2025-2030)
  • Table 266. South Korea Equine Healthcare, by Distribution Channel USD Million (2025-2030)
  • Table 267. South Korea Equine Healthcare, by Supplement USD Million (2025-2030)
  • Table 268. South Korea Equine Healthcare, by Diagnostic USD Million (2025-2030)
  • Table 269. Taiwan Equine Healthcare, by Type USD Million (2025-2030)
  • Table 270. Taiwan Equine Healthcare, by Application USD Million (2025-2030)
  • Table 271. Taiwan Equine Healthcare, by Therapeutic USD Million (2025-2030)
  • Table 272. Taiwan Equine Healthcare, by Distribution Channel USD Million (2025-2030)
  • Table 273. Taiwan Equine Healthcare, by Supplement USD Million (2025-2030)
  • Table 274. Taiwan Equine Healthcare, by Diagnostic USD Million (2025-2030)
  • Table 275. Australia Equine Healthcare, by Type USD Million (2025-2030)
  • Table 276. Australia Equine Healthcare, by Application USD Million (2025-2030)
  • Table 277. Australia Equine Healthcare, by Therapeutic USD Million (2025-2030)
  • Table 278. Australia Equine Healthcare, by Distribution Channel USD Million (2025-2030)
  • Table 279. Australia Equine Healthcare, by Supplement USD Million (2025-2030)
  • Table 280. Australia Equine Healthcare, by Diagnostic USD Million (2025-2030)
  • Table 281. Rest of Asia-Pacific Equine Healthcare, by Type USD Million (2025-2030)
  • Table 282. Rest of Asia-Pacific Equine Healthcare, by Application USD Million (2025-2030)
  • Table 283. Rest of Asia-Pacific Equine Healthcare, by Therapeutic USD Million (2025-2030)
  • Table 284. Rest of Asia-Pacific Equine Healthcare, by Distribution Channel USD Million (2025-2030)
  • Table 285. Rest of Asia-Pacific Equine Healthcare, by Supplement USD Million (2025-2030)
  • Table 286. Rest of Asia-Pacific Equine Healthcare, by Diagnostic USD Million (2025-2030)
  • Table 287. Europe Equine Healthcare, by Country USD Million (2025-2030)
  • Table 288. Europe Equine Healthcare, by Type USD Million (2025-2030)
  • Table 289. Europe Equine Healthcare, by Application USD Million (2025-2030)
  • Table 290. Europe Equine Healthcare, by Therapeutic USD Million (2025-2030)
  • Table 291. Europe Equine Healthcare, by Distribution Channel USD Million (2025-2030)
  • Table 292. Europe Equine Healthcare, by Supplement USD Million (2025-2030)
  • Table 293. Europe Equine Healthcare, by Diagnostic USD Million (2025-2030)
  • Table 294. Germany Equine Healthcare, by Type USD Million (2025-2030)
  • Table 295. Germany Equine Healthcare, by Application USD Million (2025-2030)
  • Table 296. Germany Equine Healthcare, by Therapeutic USD Million (2025-2030)
  • Table 297. Germany Equine Healthcare, by Distribution Channel USD Million (2025-2030)
  • Table 298. Germany Equine Healthcare, by Supplement USD Million (2025-2030)
  • Table 299. Germany Equine Healthcare, by Diagnostic USD Million (2025-2030)
  • Table 300. France Equine Healthcare, by Type USD Million (2025-2030)
  • Table 301. France Equine Healthcare, by Application USD Million (2025-2030)
  • Table 302. France Equine Healthcare, by Therapeutic USD Million (2025-2030)
  • Table 303. France Equine Healthcare, by Distribution Channel USD Million (2025-2030)
  • Table 304. France Equine Healthcare, by Supplement USD Million (2025-2030)
  • Table 305. France Equine Healthcare, by Diagnostic USD Million (2025-2030)
  • Table 306. Italy Equine Healthcare, by Type USD Million (2025-2030)
  • Table 307. Italy Equine Healthcare, by Application USD Million (2025-2030)
  • Table 308. Italy Equine Healthcare, by Therapeutic USD Million (2025-2030)
  • Table 309. Italy Equine Healthcare, by Distribution Channel USD Million (2025-2030)
  • Table 310. Italy Equine Healthcare, by Supplement USD Million (2025-2030)
  • Table 311. Italy Equine Healthcare, by Diagnostic USD Million (2025-2030)
  • Table 312. United Kingdom Equine Healthcare, by Type USD Million (2025-2030)
  • Table 313. United Kingdom Equine Healthcare, by Application USD Million (2025-2030)
  • Table 314. United Kingdom Equine Healthcare, by Therapeutic USD Million (2025-2030)
  • Table 315. United Kingdom Equine Healthcare, by Distribution Channel USD Million (2025-2030)
  • Table 316. United Kingdom Equine Healthcare, by Supplement USD Million (2025-2030)
  • Table 317. United Kingdom Equine Healthcare, by Diagnostic USD Million (2025-2030)
  • Table 318. Netherlands Equine Healthcare, by Type USD Million (2025-2030)
  • Table 319. Netherlands Equine Healthcare, by Application USD Million (2025-2030)
  • Table 320. Netherlands Equine Healthcare, by Therapeutic USD Million (2025-2030)
  • Table 321. Netherlands Equine Healthcare, by Distribution Channel USD Million (2025-2030)
  • Table 322. Netherlands Equine Healthcare, by Supplement USD Million (2025-2030)
  • Table 323. Netherlands Equine Healthcare, by Diagnostic USD Million (2025-2030)
  • Table 324. Rest of Europe Equine Healthcare, by Type USD Million (2025-2030)
  • Table 325. Rest of Europe Equine Healthcare, by Application USD Million (2025-2030)
  • Table 326. Rest of Europe Equine Healthcare, by Therapeutic USD Million (2025-2030)
  • Table 327. Rest of Europe Equine Healthcare, by Distribution Channel USD Million (2025-2030)
  • Table 328. Rest of Europe Equine Healthcare, by Supplement USD Million (2025-2030)
  • Table 329. Rest of Europe Equine Healthcare, by Diagnostic USD Million (2025-2030)
  • Table 330. MEA Equine Healthcare, by Country USD Million (2025-2030)
  • Table 331. MEA Equine Healthcare, by Type USD Million (2025-2030)
  • Table 332. MEA Equine Healthcare, by Application USD Million (2025-2030)
  • Table 333. MEA Equine Healthcare, by Therapeutic USD Million (2025-2030)
  • Table 334. MEA Equine Healthcare, by Distribution Channel USD Million (2025-2030)
  • Table 335. MEA Equine Healthcare, by Supplement USD Million (2025-2030)
  • Table 336. MEA Equine Healthcare, by Diagnostic USD Million (2025-2030)
  • Table 337. Middle East Equine Healthcare, by Type USD Million (2025-2030)
  • Table 338. Middle East Equine Healthcare, by Application USD Million (2025-2030)
  • Table 339. Middle East Equine Healthcare, by Therapeutic USD Million (2025-2030)
  • Table 340. Middle East Equine Healthcare, by Distribution Channel USD Million (2025-2030)
  • Table 341. Middle East Equine Healthcare, by Supplement USD Million (2025-2030)
  • Table 342. Middle East Equine Healthcare, by Diagnostic USD Million (2025-2030)
  • Table 343. Africa Equine Healthcare, by Type USD Million (2025-2030)
  • Table 344. Africa Equine Healthcare, by Application USD Million (2025-2030)
  • Table 345. Africa Equine Healthcare, by Therapeutic USD Million (2025-2030)
  • Table 346. Africa Equine Healthcare, by Distribution Channel USD Million (2025-2030)
  • Table 347. Africa Equine Healthcare, by Supplement USD Million (2025-2030)
  • Table 348. Africa Equine Healthcare, by Diagnostic USD Million (2025-2030)
  • Table 349. North America Equine Healthcare, by Country USD Million (2025-2030)
  • Table 350. North America Equine Healthcare, by Type USD Million (2025-2030)
  • Table 351. North America Equine Healthcare, by Application USD Million (2025-2030)
  • Table 352. North America Equine Healthcare, by Therapeutic USD Million (2025-2030)
  • Table 353. North America Equine Healthcare, by Distribution Channel USD Million (2025-2030)
  • Table 354. North America Equine Healthcare, by Supplement USD Million (2025-2030)
  • Table 355. North America Equine Healthcare, by Diagnostic USD Million (2025-2030)
  • Table 356. United States Equine Healthcare, by Type USD Million (2025-2030)
  • Table 357. United States Equine Healthcare, by Application USD Million (2025-2030)
  • Table 358. United States Equine Healthcare, by Therapeutic USD Million (2025-2030)
  • Table 359. United States Equine Healthcare, by Distribution Channel USD Million (2025-2030)
  • Table 360. United States Equine Healthcare, by Supplement USD Million (2025-2030)
  • Table 361. United States Equine Healthcare, by Diagnostic USD Million (2025-2030)
  • Table 362. Canada Equine Healthcare, by Type USD Million (2025-2030)
  • Table 363. Canada Equine Healthcare, by Application USD Million (2025-2030)
  • Table 364. Canada Equine Healthcare, by Therapeutic USD Million (2025-2030)
  • Table 365. Canada Equine Healthcare, by Distribution Channel USD Million (2025-2030)
  • Table 366. Canada Equine Healthcare, by Supplement USD Million (2025-2030)
  • Table 367. Canada Equine Healthcare, by Diagnostic USD Million (2025-2030)
  • Table 368. Mexico Equine Healthcare, by Type USD Million (2025-2030)
  • Table 369. Mexico Equine Healthcare, by Application USD Million (2025-2030)
  • Table 370. Mexico Equine Healthcare, by Therapeutic USD Million (2025-2030)
  • Table 371. Mexico Equine Healthcare, by Distribution Channel USD Million (2025-2030)
  • Table 372. Mexico Equine Healthcare, by Supplement USD Million (2025-2030)
  • Table 373. Mexico Equine Healthcare, by Diagnostic USD Million (2025-2030)
  • Table 374. Equine Healthcare: by Type(USD/Units)
  • Table 375. Research Programs/Design for This Report
  • Table 376. Key Data Information from Secondary Sources
  • Table 377. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Equine Healthcare: by Type USD Million (2018-2023)
  • Figure 5. Global Equine Healthcare: by Application USD Million (2018-2023)
  • Figure 6. Global Equine Healthcare: by Distribution Channel USD Million (2018-2023)
  • Figure 7. Global Equine Healthcare: by Supplement USD Million (2018-2023)
  • Figure 8. Global Equine Healthcare: by Diagnostic USD Million (2018-2023)
  • Figure 9. South America Equine Healthcare Share (%), by Country
  • Figure 10. Asia Pacific Equine Healthcare Share (%), by Country
  • Figure 11. Europe Equine Healthcare Share (%), by Country
  • Figure 12. MEA Equine Healthcare Share (%), by Country
  • Figure 13. North America Equine Healthcare Share (%), by Country
  • Figure 14. Global Equine Healthcare: by Type USD/Units (2018-2023)
  • Figure 15. Global Equine Healthcare share by Players 2023 (%)
  • Figure 16. Global Equine Healthcare share by Players (Top 3) 2023(%)
  • Figure 17. Global Equine Healthcare share by Players (Top 5) 2023(%)
  • Figure 18. BCG Matrix for key Companies
  • Figure 19. Merck Animal Health (United States) Revenue, Net Income and Gross profit
  • Figure 20. Merck Animal Health (United States) Revenue: by Geography 2023
  • Figure 21. Boehringer Ingelheim Vetmedica (Germany) Revenue, Net Income and Gross profit
  • Figure 22. Boehringer Ingelheim Vetmedica (Germany) Revenue: by Geography 2023
  • Figure 23. Affymetrix (United States) Revenue, Net Income and Gross profit
  • Figure 24. Affymetrix (United States) Revenue: by Geography 2023
  • Figure 25. Elanco Animal Heath (United States) Revenue, Net Income and Gross profit
  • Figure 26. Elanco Animal Heath (United States) Revenue: by Geography 2023
  • Figure 27. Zoetis (Pfizer Animal Health) (United States) Revenue, Net Income and Gross profit
  • Figure 28. Zoetis (Pfizer Animal Health) (United States) Revenue: by Geography 2023
  • Figure 29. Equine Health U.K. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 30. Equine Health U.K. (United Kingdom) Revenue: by Geography 2023
  • Figure 31. Nutreco N.V. (Netherlands) Revenue, Net Income and Gross profit
  • Figure 32. Nutreco N.V. (Netherlands) Revenue: by Geography 2023
  • Figure 33. Phirbo Animal Health (United States) Revenue, Net Income and Gross profit
  • Figure 34. Phirbo Animal Health (United States) Revenue: by Geography 2023
  • Figure 35. Bayer (Germany) Revenue, Net Income and Gross profit
  • Figure 36. Bayer (Germany) Revenue: by Geography 2023
  • Figure 37. Cargill (United States) Revenue, Net Income and Gross profit
  • Figure 38. Cargill (United States) Revenue: by Geography 2023
  • Figure 39. Dechra Pharmaceuticals (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 40. Dechra Pharmaceuticals (United Kingdom) Revenue: by Geography 2023
  • Figure 41. Ceva Sante Animale (France) Revenue, Net Income and Gross profit
  • Figure 42. Ceva Sante Animale (France) Revenue: by Geography 2023
  • Figure 43. Evonik Industries (Germany) Revenue, Net Income and Gross profit
  • Figure 44. Evonik Industries (Germany) Revenue: by Geography 2023
  • Figure 45. Eli Lilly and Company (United States) Revenue, Net Income and Gross profit
  • Figure 46. Eli Lilly and Company (United States) Revenue: by Geography 2023
  • Figure 47. Global Equine Healthcare: by Type USD Million (2025-2030)
  • Figure 48. Global Equine Healthcare: by Application USD Million (2025-2030)
  • Figure 49. Global Equine Healthcare: by Distribution Channel USD Million (2025-2030)
  • Figure 50. Global Equine Healthcare: by Supplement USD Million (2025-2030)
  • Figure 51. Global Equine Healthcare: by Diagnostic USD Million (2025-2030)
  • Figure 52. South America Equine Healthcare Share (%), by Country
  • Figure 53. Asia Pacific Equine Healthcare Share (%), by Country
  • Figure 54. Europe Equine Healthcare Share (%), by Country
  • Figure 55. MEA Equine Healthcare Share (%), by Country
  • Figure 56. North America Equine Healthcare Share (%), by Country
  • Figure 57. Global Equine Healthcare: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Merck Animal Health (United States)
  • Boehringer Ingelheim Vetmedica (Germany)
  • Affymetrix (United States)
  • Elanco Animal Heath (United States)
  • Zoetis (Pfizer Animal Health) (United States)
  • Equine Health U.K. (United Kingdom)
  • Nutreco N.V. (Netherlands)
  • Phirbo Animal Health (United States)
  • Bayer (Germany)
  • Cargill (United States)
  • Dechra Pharmaceuticals (United Kingdom)
  • Ceva Sante Animale (France)
  • Evonik Industries (Germany)
  • Eli Lilly and Company (United States)
Select User Access Type

Key Highlights of Report


Jan 2024 239 Pages 78 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Equine Healthcare Quantitative research analysis
Global Equine Healthcare Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Merck Animal Health (United States), Boehringer Ingelheim Vetmedica (Germany), Affymetrix (United States), Elanco Animal Heath (United States), Zoetis (Pfizer Animal Health) (United States), Equine Health U.K. (United Kingdom), Nutreco N.V. (Netherlands), Phirbo Animal Health (United States), Bayer (Germany), Cargill (United States), Dechra Pharmaceuticals (United Kingdom), Ceva Sante Animale (France), Evonik Industries (Germany) and Eli Lilly and Company (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Growing Demand for Equine Insurance in The Developed Countries" is seen as one of major influencing trends for Equine Healthcare Market during projected period 2023-2030.
The Equine Healthcare market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Equine Healthcare Report?

Have a Query? Click Here

Other Related Reports

Consumer Healthcare Products Comprehensive Study by Type (Pain Relief Product, Oral Health Product, Respiratory Product, Nutrition/Gastro Intestinal Product, Skin Health Product), Application (Hospit...
$ 3750
Sleeping Aids Comprehensive Study by Type (Medication, Mattresses and Pillows, Sleep Laboratories, Sleep Apnea Devices, Others), Application (Insomnia, Restless Legs Syndrome, Sleep Apnea, Narcolepsy...
$ 3350
Western Blotting Comprehensive Study by Type (Consumables {Reagents, Kits and Other}, Instruments {Blotting Systems (Wet and Semi-Dry) and Imagers (Chemiluminescent, Fluorescent and Other)}), Applica...
$ 3650
Orthopedic Shoes Comprehensive Study by Type (Flatfoot Orthopedic Shoes, Cavus Orthopedic Shoes, Calcaneal Spur Orthopedic Shoes, Varus and Valgus Orthopedic Shoes, Other), Application (Children, Adu...
$ 3450
Safety Syringes Comprehensive Study by Type (Retractable {Automatic, Manual}, Non Retractable {Sliding Needle , Sheathing Tube , Hinged Needle}), Application (Hospitals, Home Care), Therapy (Insulin,...
$ 3450
Prostate Cancer Comprehensive Study by Type (Hormone sensitive prostate cancer, Hormone refractory prostate cancer), Application (Chemotherapy, Hormonal Therapy, Targeted Therapy, Immunotherapy), The...
$ 3450